Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeted Next-Generation Sequencing and Genome-Wide High-Resolution Copy Number DNA Arrays Allow the Identification of Five Novel RUNX1 Fusions In Hematological Malignancies.

Vera Grossmann, Alexander Kohlmann, PhD, Hans-Ulrich Klein, MA, Sonja Schindela, Susanne Schnittger, PhD, Martin Dugas, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2010) 116 (21): 1193.

https://doi.org/10.1182/blood.V116.21.1193.1193

Published: 2010

Journal Articles

Global Identification of Genomic Structural Variants In Childhood ETV6/RUNX1 ( TEL/AML1 ) Acute Lymphoblastic Leukemias by Mate-Pair Massively Parallel Sequencing.

Vera Okpanyi, Christoph Bartenhagen, Michael Gombert, PhD, Vera Binder, MD, Hans-Ulrich Klein, MA, Silja Roettgers, PhD, Jochen Harbott, PhD, Martin Dugas, MD, Arndt Borkhardt, MD

Blood (2010) 116 (21): 3364.

https://doi.org/10.1182/blood.V116.21.3364.3364

Published: 2010

Journal Articles

Robust and Sensitive Detection of Insertions, Deletions and Point Mutations In CEBPA , a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing (NGS).

Vera Grossmann, MA, Susanne Schnittger, PhD, Sonja Schindela, Hans-Ulrich Klein, MA, Christiane Eder, PhD, Martin Dugas, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD, Alexander Kohlmann, PhD

Blood (2010) 116 (21): 1657.

https://doi.org/10.1182/blood.V116.21.1657.1657

Published: 2010

Journal Articles

Targeted Next-Generation Sequencing (NGS) Enables a Broad Screening of 95 Molecular Mutations In a One-Step Approach and Detects Recurrent Mutations In AML with a Normal Karyotype In MYH11 and NOTCH1

Alexander Kohlmann, PhD, Vera Grossmann, MA, Hans-Ulrich Klein, MA, Susanne Schnittger, PhD, Martin Dugas, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2010) 116 (21): 175.

https://doi.org/10.1182/blood.V116.21.175.175

Published: 2010

Journal Articles

The Interlaboratory RObustness of Next-Generation Sequencing (IRON) Study: Deep-Sequencing Investigating TET2 , CBL , and KRAS Mutations In 4464 Amplicons by An International Group Involving 8 Laboratories.

Blood (2010) 116 (21): 1665.

https://doi.org/10.1182/blood.V116.21.1665.1665

Published: 2010

Journal Articles

Next-Generation Sequencing (NGS) in CMML, MDS and AML Detects Molecular Mutations in Oncogenes and Allows the Identification of Balanced Chromosomal Abnormalities with Extraordinary Sensitivity and Specificity.

Vera Grossmann, MA, Alexander Kohlmann, PhD, Claudia Haferlach, MD, Hans-Ulrich Klein, MA, Martin Dugas, MD, Frank Dicker, PhD, Beray Kazak, Sonja Schindela, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2009) 114 (22): 144.

https://doi.org/10.1182/blood.V114.22.144.144

Published: 2009

NARROW

Targeted Next-Generation Sequencing and Genome-Wide High-Resolution Copy Number DNA Arrays Allow the Identification of Five Novel RUNX1 Fusions In Hematological Malignancies.

Global Identification of Genomic Structural Variants In Childhood ETV6/RUNX1 ( TEL/AML1 ) Acute Lymphoblastic Leukemias by Mate-Pair Massively Parallel Sequencing.

Robust and Sensitive Detection of Insertions, Deletions and Point Mutations In CEBPA , a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing (NGS).

Targeted Next-Generation Sequencing (NGS) Enables a Broad Screening of 95 Molecular Mutations In a One-Step Approach and Detects Recurrent Mutations In AML with a Normal Karyotype In MYH11 and NOTCH1

The Interlaboratory RObustness of Next-Generation Sequencing (IRON) Study: Deep-Sequencing Investigating TET2 , CBL , and KRAS Mutations In 4464 Amplicons by An International Group Involving 8 Laboratories.

Next-Generation Sequencing (NGS) in CMML, MDS and AML Detects Molecular Mutations in Oncogenes and Allows the Identification of Balanced Chromosomal Abnormalities with Extraordinary Sensitivity and Specificity.

Email alerts

ASH Publications

American Society of Hematology

Targeted Next-Generation Sequencing and Genome-Wide High-Resolution Copy Number DNA Arrays Allow the Identification of Five Novel RUNX1 Fusions In Hematological Malignancies.

Global Identification of Genomic Structural Variants In Childhood ETV6/RUNX1 ( TEL/AML1 ) Acute Lymphoblastic Leukemias by Mate-Pair Massively Parallel Sequencing.

Robust and Sensitive Detection of Insertions, Deletions and Point Mutations In CEBPA , a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing (NGS).

Targeted Next-Generation Sequencing (NGS) Enables a Broad Screening of 95 Molecular Mutations In a One-Step Approach and Detects Recurrent Mutations In AML with a Normal Karyotype In MYH11 and NOTCH1

The Interlaboratory RObustness of Next-Generation Sequencing (IRON) Study: Deep-Sequencing Investigating TET2 , CBL , and KRAS Mutations In 4464 Amplicons by An International Group Involving 8 Laboratories.

Next-Generation Sequencing (NGS) in CMML, MDS and AML Detects Molecular Mutations in Oncogenes and Allows the Identification of Balanced Chromosomal Abnormalities with Extraordinary Sensitivity and Specificity.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only